Theranostics is the merger between diagnostics and therapeutics as a test required for selection of patient sub-population for clinical trials or predicting responsiveness of a patient to a given drug. It covers the path for personalized medicine by involving the utilization of molecular assays for determination of dosage for the concerned patient at a given point of time. Theranostics or pharmacodiagnostics tests are applicable in the determination of drug efficacy, drug selection, risk of recurrence, and diseases progression & predisposition, dose designing. The aforementioned applications are implemented in the management of several diseases such as cancers, neurological disorders, cardiovascular diseases, immunological disorders, cardiovascular diseases, and in diverse infectious diseases.

Chapter 1 Research Methodology 

Chapter 2 Executive Summary 

Chapter 3 Market Variables, Trends& Scope

Chapter 4 Market Categorization: Therapeutic Area Estimates & Trend Analysis

Chapter 5 Market Categorization: Technology Estimates & Trend Analysis

Chapter 6 Market Categorization: Regional Estimates & Trend Analysis, by Therapeutic Area & Application

Chapter 7 Competitive Landscape